Insider Trading & Ownership of Adrian Adams

Location
Chesterbrook, PA
Summary
The estimated net worth of Adrian Adams is at least $541,013 dollars as of 24 Oct 2025. Adrian Adams is the Director of Akebia Therapeutics, Inc. and owns shares of Akebia Therapeutics, Inc. (AKBA) stock worth about $525.3K. Adrian Adams is the Director of TALPHERA, INC. and owns shares of TALPHERA, INC. (TLPH) stock worth about $15.7K.
Signature
/s/ Martha Adler, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Adrian Adams and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Quick Takeaways

  • Adrian Adams has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $541,013.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Akebia Therapeutics, Inc. ($525,310).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Adrian Adams

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AKBA Akebia Therapeutics, Inc. Director $525,310 10 Jun 2025
TLPH TALPHERA, INC. Director $15,703 23 Oct 2025
IMPL IMPEL PHARMACEUTICALS INC COB, CEO and President, Director 14 Feb 2023

Insider Transactions Reported by Adrian Adams:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .